CV
CV Sciences, Inc.
CVSI · OTC
$0.02 -0.63% (-$0.00)
1M -18.89%
Market Cap $3.87M
P/E Ratio -
Div. Yield -
ROE 132.06%
Bulios Fair Price
$0.03
59.1% upside
Trenutna cena
$0.019
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica CVSI trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
88 /100
Cheap P/B 2.46x
P/S 0.30x
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 5.24%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 15.74%
Op. margin 11.70%
FCF margin 4.10%
Quality
15 /100
Poor ROE 132.06%
ROA 30.76%
Asset turnover 1.95x
Debt
38 /100
Moderate Current ratio 0.99x
Int. coverage -4.52x
Debt/Equity 0.80x
Stability
49 /100
Moderate Rev. volatility 6.15%
EPS volatility 157.42%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CVSI
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Joseph D. Dowling
Employees
43
Headquarters
San Diego
Prihajajoči dogodki
16 NOV.
Earnings
Upcoming earnings report